DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effectiveness and acceptability of high dose
MPA (20mg oral 3 times a day) for 3 days combined with an injection of DMPA 150 mg
intramuscularly in the treatment of acute heavy, prolonged uterine bleeding who have been
identified as being eligible for outpatient management